Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06237829 · ClinicalTrials.gov registry record · NA
Testing Tactile Aids With Blind Subjects
A NA study of Blindness and Vision, Low, sponsored by University of Delaware.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06237829 is a NA study of Blindness and Vision, Low that is actively recruiting participants, run by University of Delaware. The registered enrollment target is 100 participants, above the 45-participant average among 7 other Blindness trials with a reported enrollment target (122% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06237829, a NA study of Blindness and Vision, Low, is actively recruiting participants, sponsored by University of Delaware.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this project is to create richer tactile aids by using materials chemistry to create tactile sensations in tactile aids, as an alternative to traditional physical bumps, lines, or textures. These materials are commonly used in household products, but have not yet been used to enrich tactile aids. Successful outcomes are primarily the accuracy with which low vision or blind subjects identify objects made from tactile coatings versus traditional tactile aids. Other outcomes include time to completion of the task, or the number of distinctive categories that participants can identify.
Conditions Studied
Interventions
- BEHAVIORAL Single bump acuity
- BEHAVIORAL Optimal spacing between bumps
- BEHAVIORAL Improving signal from a single bump with designer materials
Study Locations (1)
Delaware
- University of Delaware - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06237829
The ClinicalTrials.gov registry entry for NCT06237829 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 45-participant average among 7 other Blindness trials with a reported enrollment target (122% higher). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Blindness appearing as the primary indexed condition, and to 3 interventions - of which Single bump acuity is the first listed.
NCT06237829 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.
Frequently Asked Questions
What is clinical trial NCT06237829 about?
NCT06237829 is a clinical study titled "Testing Tactile Aids With Blind Subjects". The objective of this project is to create richer tactile aids by using materials chemistry to create tactile sensations in tactile aids, as an alternative to traditional physical bumps, lines, or textures. These materials are commonly used in household products, but have not yet been used to enrich...
What is the current status of trial NCT06237829?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-09-01. Estimated completion is 2027-12.
What conditions does trial NCT06237829 study?
This clinical trial studies the following conditions: Blindness, Vision, Low.
What interventions are being tested in trial NCT06237829?
The interventions under investigation include: Single bump acuity (BEHAVIORAL), Optimal spacing between bumps (BEHAVIORAL), Improving signal from a single bump with designer materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT06237829?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06237829 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blindness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind
COMPLETED · NA
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
ACTIVE NOT RECRUITING · Phase 2
-
Enhanced Tactile Memory in the Blind
COMPLETED
-
Brain Plasticity of Verbal Memory in the Blind
COMPLETED
-
Natural History Study of CEP290-Related Retinal Degeneration
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.